Trivium Point Advisory LLC Takes $2.57 Million Position in HCA Healthcare, Inc. $HCA

Trivium Point Advisory LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 6,590 shares of the company’s stock, valued at approximately $2,569,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Nomura Asset Management Co. Ltd. lifted its holdings in HCA Healthcare by 6.2% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after purchasing an additional 3,724 shares during the last quarter. Advisors Capital Management LLC boosted its holdings in shares of HCA Healthcare by 61.5% during the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after acquiring an additional 2,604 shares during the period. Liberty Wealth Management LLC bought a new stake in HCA Healthcare in the 4th quarter valued at $1,905,000. Arrowstreet Capital Limited Partnership lifted its holdings in shares of HCA Healthcare by 11.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares in the last quarter. Finally, Sunbelt Securities Inc. raised its stake in HCA Healthcare by 171.7% in the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after purchasing an additional 3,945 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.0%

Shares of NYSE HCA opened at $404.61 on Monday. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The stock’s 50 day moving average price is $393.41 and its 200-day moving average price is $446.61. The company has a market capitalization of $87.60 billion, a PE ratio of 13.55, a PEG ratio of 1.40 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company’s revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the company earned $6.84 earnings per share. As a group, research analysts expect that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is currently 10.45%.

Analysts Set New Price Targets

HCA has been the topic of several recent research reports. Wells Fargo & Company raised their target price on shares of HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a report on Monday, August 3rd. Cantor Fitzgerald reduced their target price on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a report on Tuesday, July 7th. Weiss Ratings lowered shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. Robert W. Baird cut their price target on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a research note on Monday, July 27th. Finally, Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $465.59.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.